Humana Inc (HUM) stock
HUMNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 10/3051% above fair value
$450.00+6.32 (+1.42%)
Close on Nov 13, 2026Market cap $54.04BP/E 43.6Yield 0.79%
Humana revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Humana's revenue for the twelve months ending Sep 30, 2026 was $154.19B, up 22.0% year over year. For fiscal 2025 it was $129.66B, up 10.1% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $129.66B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $129.66B | +10.1% |
| FY2024 | Dec 31, 2024 | $117.76B | +10.7% |
| FY2023 | Dec 31, 2023 | $106.37B | +14.5% |
| FY2022 | Dec 31, 2022 | $92.87B | +11.8% |
| FY2021 | Dec 31, 2021 | $83.06B | +7.7% |
| FY2020 | Dec 31, 2020 | $77.16B | +18.9% |
| FY2019 | Dec 31, 2019 | $64.89B | +14.0% |
| FY2018 | Dec 31, 2018 | $56.91B | +5.8% |
| FY2017 | Dec 31, 2017 | $53.77B | -1.1% |
| FY2016 | Dec 31, 2016 | $54.38B | +0.2% |
| FY2015 | Dec 31, 2015 | $54.29B | +11.9% |
| FY2014 | Dec 31, 2014 | $48.50B | +17.4% |
| FY2013 | Dec 31, 2013 | $41.31B | +5.6% |
| FY2012 | Dec 31, 2012 | $39.13B | +6.2% |
| FY2011 | Dec 31, 2011 | $36.83B | +9.6% |
| FY2010 | Dec 31, 2010 | $33.60B | +9.3% |
| FY2009 | Dec 31, 2009 | $30.74B | +6.2% |
| FY2008 | Dec 31, 2008 | $28.95B | +14.5% |
| FY2007 | Dec 31, 2007 | $25.29B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $41.16B | +26.1% |
| Q2 FY2026 | Jun 30, 2026 | $40.87B | +26.2% |
| Q1 FY2026 | Mar 31, 2026 | $39.65B | +23.5% |
| Q4 FY2025 | Dec 31, 2025 | $32.52B | +11.3% |
| Q3 FY2025 | Sep 30, 2025 | $32.65B | +11.1% |
| Q2 FY2025 | Jun 30, 2025 | $32.39B | +9.6% |
| Q1 FY2025 | Mar 31, 2025 | $32.11B | +8.4% |
| Q4 FY2024 | Dec 31, 2024 | $29.21B | +10.4% |
| Q3 FY2024 | Sep 30, 2024 | $29.40B | +11.3% |
| Q2 FY2024 | Jun 30, 2024 | $29.54B | +10.4% |
| Q1 FY2024 | Mar 31, 2024 | $29.61B | +10.7% |
| Q4 FY2023 | Dec 31, 2023 | $26.46B | +17.9% |
| Q3 FY2023 | Sep 30, 2023 | $26.42B | +15.9% |
| Q2 FY2023 | Jun 30, 2023 | $26.75B | +13.0% |
| Q1 FY2023 | Mar 31, 2023 | $26.74B | +11.6% |
| Q4 FY2022 | Dec 31, 2022 | $22.44B | +6.6% |
| Q3 FY2022 | Sep 30, 2022 | $22.80B | +10.2% |
| Q2 FY2022 | Jun 30, 2022 | $23.66B | +14.6% |
| Q1 FY2022 | Mar 31, 2022 | $23.97B | +16.0% |
| Q4 FY2021 | Dec 31, 2021 | $21.05B | +10.5% |
| Q3 FY2021 | Sep 30, 2021 | $20.70B | +3.1% |
| Q2 FY2021 | Jun 30, 2021 | $20.65B | +8.2% |
| Q1 FY2021 | Mar 31, 2021 | $20.67B | +9.2% |
| Q4 FY2020 | Dec 31, 2020 | $19.06B | +17.0% |
| Q3 FY2020 | Sep 30, 2020 | $20.08B | +23.6% |
| Q2 FY2020 | Jun 30, 2020 | $19.08B | +17.5% |
| Q1 FY2020 | Mar 31, 2020 | $18.94B | +17.6% |
| Q4 FY2019 | Dec 31, 2019 | $16.30B | +15.0% |
| Q3 FY2019 | Sep 30, 2019 | $16.24B | +14.3% |
| Q2 FY2019 | Jun 30, 2019 | $16.25B | +13.9% |
| Q1 FY2019 | Mar 31, 2019 | $16.11B | +12.8% |
| Q4 FY2018 | Dec 31, 2018 | $14.17B | +7.4% |
| Q3 FY2018 | Sep 30, 2018 | $14.21B | +7.0% |
| Q2 FY2018 | Jun 30, 2018 | $14.26B | +5.4% |
| Q1 FY2018 | Mar 31, 2018 | $14.28B | +3.8% |
| Q4 FY2017 | Dec 31, 2017 | $13.19B | +2.4% |
| Q3 FY2017 | Sep 30, 2017 | $13.28B | – |
| Q2 FY2017 | Jun 30, 2017 | $13.53B | – |
| Q1 FY2017 | Mar 31, 2017 | $13.76B | – |
| Q4 FY2016 | Dec 31, 2016 | $12.88B | – |
See a number that looks wrong?